Coronavirus (SARS-CoV-2): a systematic review for potential vaccines

Coronavirus (SARS-CoV-2): a systematic review for potential vaccines

COVID-19 is an international public health emergency in need of effective and safe vaccines for SARS-CoV-2. A systematic review has been done to analyze the availability, development and status of new COVID-19 vaccine candidates as well as the status of vaccines for other diseases that might be effe...

Full description

Bibliographic Details
Main Authors:	Mihir Bhatta, Srijita Nandi, Shanta Dutta, Malay Kumar Saha
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-01-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	sars-cov-2 vaccine candidates coronavirus covid-19 clinical trial vaccine development
Online Access:	http://dx.doi.org/10.1080/21645515.2020.1865774

Similar Items

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
by: Salman Sadullah Usmani, et al.
Published: (2020-09-01)

SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus
by: Laila Elmancy, et al.
Published: (2022-12-01)

Vaccines against Coronaviruses: The State of the Art
by: Cristiano Conte, et al.
Published: (2020-06-01)

An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
by: Alejandro Pascual-Iglesias, et al.
Published: (2021-08-01)

Platforms Exploited for SARS-CoV-2 Vaccine Development
by: Shilu Mathew, et al.
Published: (2020-12-01)

A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
by: Colin D. Funk, et al.
Published: (2020-06-01)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
by: Utkarsh Srivastava, et al.
Published: (2022-10-01)

SARS-CoV-2 virus: Vaccines in development
by: Qingrui Huang, et al.
Published: (2021-03-01)

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
by: Rajat Mudgal, et al.
Published: (2020-12-01)

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
by: Jonny Jonny, et al.
Published: (2022-09-01)

Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
by: Jawad Al-Kassmy, et al.
Published: (2020-08-01)

Frequency of SARS-CoV-2 RNA Detection in Foreign Medical Students Vaccined against New Coronavirus Infection
by: O. A. Ryabtseva, et al.
Published: (2023-03-01)

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronavirusesResearch in context
by: Peter J. Halfmann, et al.
Published: (2022-12-01)

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
by: Syed Faraz Ahmed, et al.
Published: (2020-02-01)

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
by: Ebenezer Tumban
Published: (2020-12-01)

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine
by: Eddie Underwood, et al.
Published: (2023-12-01)

Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
by: Soheil Ghasemi, et al.
Published: (2021-11-01)

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
by: Cielo García-Montero, et al.
Published: (2021-04-01)

Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity
by: Mark Yarmarkovich, et al.
Published: (2020-06-01)

Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach
by: Ysrafil Ysrafil, et al.
Published: (2022-07-01)

Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study
by: Rami H. Al-Rifai, et al.
Published: (2023-01-01)

Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial
by: Parichehr Shamsrizi, et al.
Published: (2021-10-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

Efficacy and Safety of AZD1222, BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2
by: Ilir Alimehmeti
Published: (2021-01-01)

Immune Response to SARS-CoV-2 Vaccines
by: Navya Bellamkonda, et al.
Published: (2022-06-01)

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
by: Wen-Hsiang Chen, et al.
Published: (2020-06-01)

A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development
by: Priscila M. S. Castanha, et al.
Published: (2020-11-01)

A novel coronavirus (SARS-CoV-2): current status and challenges
by: Nilay Vishal Singh, et al.
Published: (2022-05-01)

SARS-CoV-2 vaccine development and challenges
by: Duan Fugang, et al.
Published: (2021-03-01)

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
by: Christina M. Kackos, et al.
Published: (2023-02-01)

COVID-19 Infection Detection and Prevention by SARS-CoV-2 Active Antigens: A Synthetic Vaccine Approach
by: José Manuel Lozano, et al.
Published: (2020-11-01)

Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination
by: A. Riccomi, et al.
Published: (2024-04-01)

Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in Escherichia coli
by: Intan Aghniya Safitri, et al.
Published: (2024-01-01)

Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes
by: Burkitkan Akbay, et al.
Published: (2021-06-01)

Proposed therapies and vaccine developing for COVID-19 (SARS CoV-2)
by: Gamal, Abdelaziz, et al.
Published: (2020-06-01)

SARS-CoV-2 vaccine candidates in rapid development
by: Lifeng Li, et al.
Published: (2021-03-01)

Recent Update of COVID-19 Vaccines
by: Sameer A. Jadaan, et al.
Published: (2022-03-01)

Demographic, psychological, and experiential correlates of SARS-CoV-2 vaccination intentions in a sample of Canadian families
by: Christine L. Lackner, et al.
Published: (2021-08-01)

Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis
by: María E. Sanhueza, et al.
Published: (2023-01-01)

Modern vaccines and coronavirus infections
by: Yu. A. Belikova, et al.
Published: (2020-12-01)